Toll-like receptors (TLRs) are expressed in human bone marrow-derived mesenchymal stromal cells (BM-MSCs), and the activation of TLRs is important in proliferation, differentiation, migration and hematopoiesis-supporting functions of BM-MSCs. However, the molecular mechanisms underlying these processes remain to be elucidated. MicroRNAs (miRNAs) are involved in various biological functions by mediating mRNA degradation or inhibiting translation of target genes. The present study aimed to identify whether TLRs regulate the expression of miRNAs in BM-MSCs and elucidate the regulatory roles of miRNAs. Illumina high-throughput sequencing was used to profile miRNAs expressed in BM-MSCs stimulated with TLR2 agonist, PAM 3 CSK4 (PM) or TLR4 agonist, lipopolysaccharides (LPS). A marked expression change upon PM or LPS treatment was observed for 164 known miRNAs and six novel miRNAs that were identified. The expression of six novel miRNAs and 40 randomly selected known miRNAs was further validated by reverse transcription-quantitative polymerase chain reaction. In addition, bioinformatic methods were used to predict the potential target genes of the abundant known miRNAs. The gene ontology analysis demonstrated that predicted targets were enriched in the regulation of signal transduction, cellular processes and macromolecule meta-bolic processes. Kyoto Encyclopedia of Genes and Genomes pathway analysis suggested that these potential targets were involved in numerous important pathways, predominantly including mitogen-activated protein kinase, phosphatidylinositol-4,5-bisphosphate 3-kinase-Akt, neurotrophin and cancer-associated signaling pathways. The present study aimed to identify the global expression change of miRNAs in BM-MSCs stimulated with LPS and PM, providing the opportunity to further elucidate the roles of miRNAs in mediating TLR signals to regulate the functions of BM-MSCs.
Introduction
MicroRNAs (miRNAs) are a class of small non-coding RNAs (length, ~22 nt) that regulate gene expression at the post-transcriptional levels. miRNAs are involved in the regulation of the majority of important biological events, including differentiation, growth, proliferation, survival, signal transduction and immune response (1) (2) (3) . However, the roles of miRNAs in regulating the activation of human bone marrow-derived mesenchymal stromal cells (BM-MSCs) remain to be elucidated.
The BM-MSCs are multipotent cells that differentiate into osteoblasts, adipocytes, chondrocytes and other tissue cells (4) (5) (6) (7) . It has been demonstrated that toll-like receptors (TLRs) are expressed in MSCs to modulate their proliferation, cytokine secretion, differentiation, hematopoiesis-supporting functions and immunosuppressive capacity (8) (9) (10) . Notably, it is well established that TLRs induce multiple miRNAs, which regulate TLR-signaling responses at multiple levels. For example, TLR2 and TLR4 are repressed by expression of miR-105, miR-146 and the let-7 miRNA family (11) (12) (13) (14) . However, miR-155 and miR-146b directly target numerous TLR signaling proteins (15, 16) . Regulatory molecules, TLR-induced transcription factors and the inflammatory cytokines are also regulated by miRNAs, including miR-155 (17) .
It has previously been verified that pre-stimulation with the TLR2 agonist, PAM 3 CSK4 (PM) or the TLR4 agonist, lipopolysaccharides (LPS) enables BM-MSCs to enhance CD34 + cell proliferation and differentiation towards the myeloid lineage (10) . To further elucidate the roles of miRNAs in mediating TLR-induced BM-MSC activation, the present Identification of TLR2 and TLR4-induced microRNAs in human mesenchymal stem cells and their possible roles in regulating TLR signals study aimed to determine the miRNA expression profiles in unstimulated BM-MSCs and PM/LPS-stimulated BM-MSCs, using high-throughput Illumine HiSeq 2000 technology. Bioinformatic methods were also used to predict the potential target genes of the abundant known miRNAs. Furthermore, data from the present study indicated that miRNAs are involved in various important functions in human BM-MSCs, including the TLR signaling pathway.
Materials and methods
Isolation and culture of BM-MSCs. BM-MSCs were isolated from fresh bone marrow by sterile puncture of a healthy donor. The present study was approved by the Anhui Medical University Ethics Committee, and informed written consent was obtained from the donor. The isolation, expansion and identification of BM-MSCs were performed as described previously (10) . Briefly, following density gradient centrifugation over Ficoll-Hypaque ( com/products/novoalign/). Reads (<2 counts) were discarded when calculating the miRNA expression. In order to characterize the isomiR variability, any sequence that matched the miRNA precursors in the mature miRNA region ±4 nt (with ≤1 mismatch) were accepted as mature miRNA isomiRs, which were grouped according to the 5-prime (5p) or 3-prime (3p) arm of the precursor hairpin.
Prediction of novel miRNAs. miRDeep2 (http://www. mdc-berlin.de/en/research/research_teams/systems_biology_ of_gene_regulatory_elements/projects/miRDeep) was used to predict novel miRNAs. For novel miRNA prediction, all sequence data was pooled from the following 3'-adapter trimmed files: LPS, PM and con-trimmed_tags.fa, all adapter trimmed sequences of length <17 bp and mismatch >1 were excluded from the prediction pipeline. The higher the novel miRNA score of the miRDeep2, the more reliable the novel miRNA was considered to be. The annotated miRNA target genes that were selected from all the algorithms were considered to be the target genes.
Gene ontology (GO) and Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathway analysis of the predicted miRNA target genes. In order to further realize the functions, the predicted target genes were subjected to the analysis of GO project (http://www.geneontology.org). Fisher's exact test was used to find whether there was increased overlap between the DE list and the GO annotation list than would be expected by chance. The P-value denotes the significance of GO term enrichment in the DE genes; the lower the P-value, the more significant the GO term (P<0.05 is recommended). Furthermore, pathway analysis was performed for these target genes. Pathway analysis is a functional analysis that maps genes to the KEGG pathways. The P-value (EASE-score, Fisher's method P-value or hypergeometric P-value) indicates the significance of the pathway correlated to the conditions. A lower P-value, indicates a more significant pathway (P<0.05 is recommended).
Validation of miRNA expression by quantitative PCR (qPCR).
A random selection of DE miRNAs between the experimental and control groups from the sequencing data was validated by qPCR. Corroboration of the six novel miRNAs was performed according to the previously described conditions using qPCR assays. Total RNA was isolated from each transcripts, the primer sequences were forward, 5'-GCT TCG GCA GCA CAT ATA CTA AAAT-3' and reverse, 5'-CGC TTC ACG AAT TTG CGT GTCAT-3' for U6. Relative expression of miRNA was evaluated by the 2 -ΔΔCq method (18) . All miRNA samples and the internal reference U6 were run in a qPCR reaction. Thermal cycling conditions of the qPCR were 95˚C (Table II) . In PM-treated cells, the downregulation (Table III) and upregulation (Table IV) were observed for 51 and 46 miRNAs, respectively. To assess the sequencing quality, the length distribution of the clean reads was summarized. Few differences were observed in the length distribution of the sequences from the control and trial libraries (Fig. 1) . The most abundant sequence reads were 22, 23, 21 and 24 nt in length, which is consistent with the typical small RNA distribution of mammals. HiSeq 2000 technology, 40 known miRNAs from Tables I-IV were randomly selected for further validation with additional samples by qPCR. As presented in Fig. 2 , the qPCR data were highly consistent with Illumine HiSeq 2000 technology, confirming the reliability of the HiSeq 2000 sequencing data.
Results

Overview of LPS and PM-induced miRNA expression
qPCR verification of known miRNAs. For identification of the authenticity of the miRNAs detected by Illumine
Novel miRNA identification. To identify the novel, unannotated miRNAs in human BM-MSCs, the unlabeled reads were analyzed by miRDeep2. The present study focused on six potential novel miRNAs with the most frequent appearance among all the samples and the highest miRDeep2 score. The expression levels of these six miRNAs were further validated by qPCR. Compared with Illumine HiSeq 2000 sequencing, qPCR indicated the same trend of expression levels for the six novel miRNA candidates (Fig. 3) . 
Predicted target genes of LPS-and PM-responsive miRNAs.
To characterize the DE miRNAs between LPS, PM and the controls, the target genes of the DE miRNAs were predicted using three different miRNA target prediction algorithms (TargetScan, MicroCosm and miRanda). Subsequently, the target genes that were identified in all three databases underwent GO analysis. In the LPS group, the targets genes of downregulated miRNAs were significantly enriched in transcripts from the RNA polymerase II promoter and included regulation of macromolecule metabolic processes, gene expression and nucleobase-containing compound metabolic processes; the most enriched GO terms of targets genes of upregulated miRNAs included anatomical structure morphogenesis, regulation of cellular processes, biological processes and cell development. In the PM group, significantly enriched GO terms of targets genes of downregulated miRNAs included regulation of biological process, system development, transcription from RNA polymerase II promoter and cell differentiation; the most enriched GO terms of targets genes of downregulated miRNAs included regulation of signal transduction, cellular process, cell communication and biological process (Fig. 4) . KEGG pathway analysis indicated that the predicted target genes were significantly enriched in a wide range of pathways. LPS-regulated miRNAs predominantly target mitogen activated protein kinases (MAPKs), estrogen, T cell receptors, phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3)-Akt, the mammalian target of rapamycin signaling pathway and cancer-associated signaling pathways, while PM-regulated miRNAs target the P13-Akt, ras-related protein 1, neurotrophin, MAPK and Ras signaling pathways (Fig. 5 ).
Discussion
A number of studies have reported the expression of TLRs upon MSC and TLR activation in MSCs regulates their functions in immunomodulation, migration, repair and regeneration of damaged tissues/organs (19) (20) (21) (22) (23) (24) . In addition, a previous study reported that TLR2 agonists (PM) and/or TLR4 agonists (LPS) were able to activate MSCs, thus modulating their hematopoiesis-supporting role in vitro (10) . The present study hypothesized that the miRNAs induced by TLR activation may control MSC processes, including immunomodulation, migration, and repair and regeneration of damaged tissues/organs. The present study analyzed the differential miRNA expression profiles in the MSCs derived from 
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human fresh bone marrow and stimulated with LPS or PM. By high-throughput sequencing, compared with the expression levels in unstimulated MSCs, 67 miRNAs were identified with 35 miRNAs upregulated and 32 downregulated following LPS stimulation; 97 miRNAs with 46 miRNAs upregulated and 51 downregulated following PM stimulation. Data from the present study demonstrated that the responses to LPS or PM prompted quick and specific in vitro alterations to the miRNA expression profile of BM-MSCs. miR-425, which has been demonstrated to be DE and the most markedly downregulated, was observed in the LPS and PM-stimulated BM-MSCs. It was reported that upregulated expression of miR-425 was associated with a variety of types of cancer, including renal and gastric cancers (25, 26) . A recent study demonstrated that nuclear factor-κB (NF-κB)-dependent miR-425 upregulation promotes gastric cancer cell growth by targeting phosphatase and tensin homolog in response to IL-1β treatment (25, 26) . Furthermore, this indicates that the action of miR-425 may mediate cell proliferation. However, to the best of our knowledge, there are no reports investigating the effects of miR-425 in BM-MSCs. Compared with previous studies, the marked difference in expression level of miR-425 indicates that miRNAs may respond differently in LPS or PM-stimulated BM-MSCs and exert different effects in the different groups.
In accordance with the miRNA results demonstrating upregulation of miR-199a in human BM-MSCs during osteoblastic differentiation and chondrogenesis (27) , the most abundantly expressed miRNA in LPS-stimulated BM-MSCs was miR-199a, which was also upregulated in LPS-stimulated leukocytes derived from cord blood (CB) (28) . Laine et al (27) demonstrated that cells transfected with pre-miR-199a reduced the proliferation of human MSCs and miR-199a restricts chondrogenic differentiation by suppressing the expression of SRY-box 9, which is a positive regulator of chondrogenesis (29) . In addition, miR-199a has been identified as a negative regulator of chondrogenesis (30) . Wu et al (31) inferred that the overexpression of miR-199a-5p inhibits the proliferation of keloid fibroblasts. However, Shi et al (32) demonstrated that overexpression of miR-199a-5p promoted the proliferation of porcine preadipocytes and suppressed adipogenic differentiation. These findings indicate that increased expression of miR-199a in LPS-stimulated BM-MSCs may be a key regulator for MSC differentiation and proliferation. As miR-199 was observed to exert opposing effects on proliferation in different cells, this is likely explained by miRNA-mRNA targeting, and the different interactions among tissue and cell types and physiological/pathological conditions (33) . Further studies are required to investigate the exact underlying mechanism of miR-199a action in BM-MSCs.
The miRNA that was most abundantly expressed in human PM-stimulated BM-MSCs was miR-214. Previous studies reported that miR-214 may be important in promoting myoblast proliferation and differentiation (34) ; overexpression of miR-214 was connected to gastric cancer tissue, and deletion of miR-214 inhibited the proliferation, migration and invasion of gastric cancer cells (35) . The results are consistent with recent findings by Zhang et al (36) , that miR-214 is overexpressed in nasopharyngeal carcinoma tissues and cell lines, and that knockdown of miR-214 suppressed cell proliferation and induced apoptosis. However, Derfoul et al (37) , demonstrated that overexpression of miR-214 inhibited the proliferation and invasion of breast cancer cells. Thus, the abnormal expression of miR-214 may be closely associated with certain types of cancer by affecting cell growth, differentiation and migration.
However, whether the TLR signaling pathway is regulated by the above-mentioned miRNAs, which are expressed most differentially, and whether their target genes are involved in TLR signal transduction, requires further investigation.
To investigate the function of the LPS-or PM-induced DE miRNAs further, the target genes were predicted, and GO and KEGG pathway analyses were applied to these predicted target genes. The GO term annotation suggests that the presumed target genes of these DE miRNAs in BM-MSCs are involved in a broad range of physiological processes in response to stimuli. Consistent with the GO assay, among those pathways, the MAPK and PI3-Akt signaling pathway are notable, as they have been reported to be important in promoting cell proliferation, growth and differentiation (38) .
Notably, in the present study, a number of the verified TLR signaling pathway-associated miRNAs were markedly DE between the control and trial groups. For example, in the TLR4 agonist group, the associated markedly DE miRNAs were miR-146a, miR-155, miR-132, miR-29, miR-199a-5p, let-7b, miR-24,miR-221, miR-181, miR-106a/b, miR-20a, miR-26a and miR-34a (14, 15, (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) . In the TLR2 agonist group, the associated markedly DE miRNAs were miR-146a/b, miR-155, miR-132, miR-29, miR-199a-3p, let-7b, miR-24, miR-221, miR-181, miR-106b, miR-92a, miR-210, miR-27b, miR-21, miR-125b, miR-101 and miR-148a/b (12, 15, 16, (38) (39) (40) (41) (42) (43) (44) (45) (49) (50) (51) (52) (53) (54) . These miRNAs in BM-MSCs may suggest a potentially important role in TLR signaling regulation. Furthermore, miR-146b was observed to be upregulated in CB leukocytes following LPS stimulation and may control LPS-stimulated neonatal early phases of inflammation via negative feedback loops (28) . Ma et al (55) reported that miR-301a was upregulated in umbilical cord-MSCs stimulated with LPS, while miR-301a was not regulated by LPS and PM in the dataset produced in the present study, this notable difference is likely due to the different experimental methods and sources of material.
TLR activation triggers myeloid differentiation primary response gene 88-dependent and -independent downstream signaling cascades, leading to the activation of a number of transcription factors and genes (56-61). These downstream signaling molecules predominantly include transforming growth factor-β-activated kinase, IL-1R-associated kinases, MAPKs, NF-κB and tumor necrosis factor-receptor-associated factor 6 (59) . It has been demonstrated that following stimulation with ligands specific to TLRs, the NF-κB, MAPK, and PI3K signaling pathways were activated with a subsequent induction of multiple genes and cytokines (62) . Furthermore, combined with KEGG pathways analysis, the results of the present study indicate a critical role for miRNAs, via the TLR signaling pathway, in the growth, differentiation, and migration of LPS and PM-induced BM-MSCs.
During comparison of these two sets of experiments, a number of the TLR signaling pathway-associated miRNAs (miR-146a, miR-155, let-7b, miR-106b, miR-132, miR-29, miR-221 and miR-181) were found to be the same, and the up-or downregulation of specific miRNAs was also consistent, suggesting that LPS-or PM-induced miRNAs may have common targets and exert similar effects in BM-MSCs. Future studies are required to validate these predictions.
Six novel miRNAs that demonstrated marked changes in response to TLR activation were observed in the present study, which were not similar to any known miRNAs. Future investigations are required to predict and functionally validate these DE miRNA targets.
In conclusion, the results of the current study identify the global expression change of miRNAs in BM-MSCs stimulated with LPS and PM, providing a framework for further analysis of miRNAs and their role in mediating TLR signals to regulate the functions of BM-MSCs.
